134 related articles for article (PubMed ID: 37555960)
1. No gender differences in the pharmacological emergency treatment of schizophrenia: results of a 21-year observation.
Edlinger M; Brettbacher S; Schurr T; Yalcin-Siedentopf N; Hofer A
Int Clin Psychopharmacol; 2024 Jan; 39(1):36-41. PubMed ID: 37555960
[TBL] [Abstract][Full Text] [Related]
2. Trends in pharmacological emergency treatment of patients suffering from schizophrenia over a 16-year observation period.
Edlinger M; Welte AS; Yalcin-Siedentopf N; Kemmler G; Neymeyer F; Fleischhacker WW; Hofer A
Int Clin Psychopharmacol; 2018 Jul; 33(4):197-203. PubMed ID: 29664808
[TBL] [Abstract][Full Text] [Related]
3. Characteristics of Involuntarily Admitted Patients and Treatment Patterns Over a 21-Year Observation Period.
Welte AS; Edlinger M; Kemmler G; Yalcin-Siedentopf N; Fleischhacker WW; Hofer A
J Clin Psychopharmacol; 2018 Aug; 38(4):376-379. PubMed ID: 29851706
[TBL] [Abstract][Full Text] [Related]
4. Gender differences in response to antipsychotic treatment in outpatients with schizophrenia.
Usall J; Suarez D; Haro JM;
Psychiatry Res; 2007 Dec; 153(3):225-31. PubMed ID: 17681611
[TBL] [Abstract][Full Text] [Related]
5. [Metabolic side effects of risperidone in early onset schizophrenia].
Goeb JL; Marco S; Duhamel A; Kechid G; Bordet R; Thomas P; Delion P; Jardri R
Encephale; 2010 Jun; 36(3):242-52. PubMed ID: 20620267
[TBL] [Abstract][Full Text] [Related]
6. Suicidality and second generation antipsychotics in schizophrenia patients: a case-controlled retrospective study during a 5-year period.
Barak Y; Mirecki I; Knobler HY; Natan Z; Aizenberg D
Psychopharmacology (Berl); 2004 Sep; 175(2):215-9. PubMed ID: 14760515
[TBL] [Abstract][Full Text] [Related]
7. Letter to the Editor: Rethinking The Cost Of Antipsychotic Treatment: The Average Cost Of The Drugs Used In Turkey In 2020.
Yıldız M; Osman E
Turk Psikiyatri Derg; 2022; 33(2):146-148. PubMed ID: 35730516
[TBL] [Abstract][Full Text] [Related]
8. [Retrospective study of clozapine use in Ile-de-France].
Hiltgen S; Mantelet S; Pinabel F; Enjaume F
Encephale; 2006 Oct; 32(5 Pt 1):688-96. PubMed ID: 17099592
[TBL] [Abstract][Full Text] [Related]
9. Acute weight gain, gender, and therapeutic response to antipsychotics in the treatment of patients with schizophrenia.
Ascher-Svanum H; Stensland M; Zhao Z; Kinon BJ
BMC Psychiatry; 2005 Jan; 5():3. PubMed ID: 15649317
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular disease mortality in patients with chronic schizophrenia treated with clozapine: a retrospective cohort study.
Kelly DL; McMahon RP; Liu F; Love RC; Wehring HJ; Shim JC; Warren KR; Conley RR
J Clin Psychiatry; 2010 Mar; 71(3):304-11. PubMed ID: 20079332
[TBL] [Abstract][Full Text] [Related]
11. Relationship between antipsychotic medication treatment and new cases of diabetes among psychiatric inpatients.
Citrome L; Jaffe A; Levine J; Allingham B; Robinson J
Psychiatr Serv; 2004 Sep; 55(9):1006-13. PubMed ID: 15345760
[TBL] [Abstract][Full Text] [Related]
12. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
13. [Clinical diagnosis and drug therapy of elderly patients with schizophrenia : A restrospective analysis of data in a department of old age psychiatry].
Jagsch C; Dietmaier G; Jagsch M; Kurz M
Neuropsychiatr; 2016 Jun; 30(2):74-81. PubMed ID: 27294270
[TBL] [Abstract][Full Text] [Related]
14. One-Year Outcome and Adherence to Pharmacological Guidelines in First-Episode Schizophrenia: Results From a Consecutive Cohort Study.
Drosos P; Brønnick K; Joa I; Johannessen JO; Johnsen E; Kroken RA; Stain HJ; Hegelstad WTV; Larsen TK
J Clin Psychopharmacol; 2020; 40(6):534-540. PubMed ID: 33136922
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis.
Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S
JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482
[TBL] [Abstract][Full Text] [Related]
16. Predictors of remission during acute treatment of first-episode schizophrenia patients involuntarily hospitalized and treated with algorithm-based pharmacotherapy: Secondary analysis of an observational study.
Yoshimura B; Sakamoto S; Sato K; Takaki M; Yamada N
Early Interv Psychiatry; 2019 Jun; 13(3):589-597. PubMed ID: 29498481
[TBL] [Abstract][Full Text] [Related]
17. Time to discontinuation of atypical versus typical antipsychotics in the naturalistic treatment of schizophrenia.
Ascher-Svanum H; Zhu B; Faries D; Landbloom R; Swartz M; Swanson J
BMC Psychiatry; 2006 Feb; 6():8. PubMed ID: 16504026
[TBL] [Abstract][Full Text] [Related]
18. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
19. Reducing Restraint With Clozapine in Involuntarily Admitted Patients With Schizophrenia.
Ifteni P; Szalontay AS; Teodorescu A
Am J Ther; 2017; 24(2):e222-e226. PubMed ID: 27984264
[TBL] [Abstract][Full Text] [Related]
20. Trends in the pharmacological treatment of patients with schizophrenia over a 12 year observation period.
Edlinger M; Hausmann A; Kemmler G; Kurz M; Kurzthaler I; Walch T; Walpoth M; Fleischhacker WW
Schizophr Res; 2005 Sep; 77(1):25-34. PubMed ID: 16005382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
